Candriam S.C.A. Fibrogen Inc Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$9.93 - $15.39 $2.86 Million - $4.44 Million	-288,484 Closed	0 $0
Q2 2021 Jul 20, 2021	BUY	$18.57 - $35.68 $1.93 Million - $3.71 Million	103,859 Added 56.25%	288,484 $7.68 Million
Q4 2020 Jan 22, 2021	SELL	$37.09 - $48.97 $2.54 Million - $3.35 Million	-68,416 Reduced 27.04%	184,625 $6.85 Million
Q3 2020 Oct 19, 2020	BUY	$40.47 - $45.5 $1.58 Million - $1.78 Million	39,141 Added 18.3%	253,041 $10.4 Million
Q2 2020 Jul 23, 2020	SELL	$32.57 - $42.83 $569,975 - $749,525	-17,500 Reduced 7.56%	213,900 $8.67 Million
Q4 2019 Jan 21, 2020	SELL	$34.58 - $48.06 $8.87 Million - $12.3 Million	-256,500 Reduced 52.57%	231,400 $10,000
Q3 2019 Oct 21, 2019	BUY	$36.98 - $48.45 $16.2 Million - $21.2 Million	436,900 Added 856.67%	487,900 $18,000
Q2 2019 Aug 01, 2019	SELL	$35.13 - $55.53 $8.43 Million - $13.3 Million	-239,900 Reduced 82.47%	51,000 $2.29 Million
Q1 2019 May 02, 2019	SELL	$42.83 - $59.91 $2.57 Million - $3.59 Million	-60,000 Reduced 17.1%	290,900 $15.8 Million
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $2.28 Million - $3.61 Million	-60,000 Reduced 14.6%	350,900 $16.2 Million
Q3 2018 Nov 07, 2018	BUY	$56.3 - $67.25 $12.5 Million - $15 Million	222,800 Added 118.45%	410,900 $25 Million
Q2 2018 Aug 14, 2018	BUY	$44.9 - $64.95 $1.55 Million - $2.25 Million	34,600 Added 22.54%	188,100 $11.8 Million
Q1 2018 May 09, 2018	SELL	$45.35 - $61.65 $453,500 - $616,500	-10,000 Reduced 6.12%	153,500 $7.09 Million
Q4 2017 Feb 07, 2018	SELL	$41.95 - $60.1 $3.57 Million - $5.11 Million	-85,000 Reduced 34.21%	163,500 $7.75 Million
Q3 2017 Nov 03, 2017	BUY	$33.4 - $53.9 $8.3 Million - $13.4 Million	248,500	248,500 $13.4 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account